Comparison of B-type natriuretic peptide and left ventricular dysfunction in patients with constrictive pericarditis

Poonam Malhotra Kapoor1, Vikram Aggarwal, Ujjwal Chowdhury

  • 1Department of Cardiothoracic Vascular Anesthesia, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110 029, India. drpoonamaiims@gmail.com

Insights

Brain natriuretic peptide (BNP) can effectively monitor left ventricular diastolic dysfunction after pericardiectomy in tuberculosis-related constrictive pericarditis patients. BNP levels significantly decreased post-surgery, correlating with improved diastolic function markers.

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Diagnostics

Background:

  • Tuberculosis-related chronic constrictive pericarditis (CCP) poses significant perioperative risks, particularly left ventricular (LV) dysfunction.
  • Left ventricular dysfunction, both systolic and diastolic, is a major contributor to morbidity and mortality following pericardiectomy for CCP.

Purpose of the Study:

  • To prospectively evaluate Brain-type natriuretic peptide (BNP) as a marker for LV diastolic dysfunction in CCP patients undergoing pericardiectomy.
  • To compare BNP levels with transmitral Doppler flow velocities (E/A ratio) as indicators of diastolic function pre- and post-surgery.

Main Methods:

  • A prospective study involving 24 CCP patients undergoing pericardiectomy.
  • Measurement of BNP levels and transmitral Doppler E/A ratio pre- and post-operatively.
  • Assessment of LV systolic parameters including stroke volume index and cardiac index.

Main Results:

  • Significant reductions in mean log BNP levels (6.19 to 4.65, P=0.001) and E/A ratio (1.81 to 1.01, P=0.001) were observed post-pericardiectomy.
  • Strong positive correlations (r=0.896 and 0.837) were found between BNP and E/A ratio both pre- and post-operatively.
  • Significant improvements in LV systolic parameters were noted, but without correlation to BNP levels.

Conclusions:

  • BNP serves as a reliable marker for LV diastolic dysfunction in CCP patients undergoing pericardiectomy, potentially replacing the E/A ratio.
  • Further studies are warranted to validate BNP as a diagnostic tool for diastolic dysfunction in this patient population.

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...